Mpox virus can also infect the brain, say Swiss scientists
According to a new study, the Mpox virus can also infect the brain
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Mpox virus can also infect the brain, say Swiss scientists
The Mpox virus can also infect the human brain and damage brain cells. In view of the recent worldwide increase in Mpox cases, these new findings are of great importance, according to the University of Bern.
This content was published on
3 minutes
Keystone-SDA
Deutsch
de
Das Mpox-Virus kann laut einer neuen Studie auch das Hirn befallen
Original
This is not only for virology and neurobiology, but also from a public health perspective, the university and the Institute of Virology and Immunology (IVI) wrote in a press release on Monday.
The disease Mpox, formerly known as monkeypox, has spread rapidly in many countries in recent years. The disease is often mild, with flu-like symptoms and a rash. However, serious complications can also occur, as the university emphasised. Around 3% of all people infected with the Mpox virus (MPXV) between 1985 and 2021 developed neurological symptoms such as seizures or encephalitis. Some cases were fatal.
Nevertheless, the extent to which the virus affects the human central nervous system is still poorly understood, according to the University of Bern. In collaboration with Lausanne University Hospital (CHUV) and the Spiez Federal Laboratory, researchers from the University of Bern and the IVI therefore investigated whether the virus can spread in the human brain.
To do this, they used so-called brain organoids, three-dimensional mini-brains grown in the laboratory from human stem cells. These were exposed to a virus sample that had been isolated from a patient during the 2022 Mpox outbreak.
The scientists then observed how the virus spread from cell to cell. This led to the formation of so-called neuritic beads, bead-like thickenings that are also known from neurodegenerative diseases such as Alzheimer’s. The formation of these thickenings precedes the death of the nerve cells.
The research team also tested the effect of the antiviral drug Tecovirimat. The treatment was able to significantly reduce the viral load in the brain organoids. The results were published on Monday in the scientific journal Nature Communications.
Translated from German by DeepL/ts
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
This content was published on
Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.
This content was published on
Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.
Fewer attacks on Swiss ATMs but their future remains uncertain
This content was published on
Bank ATMs in Switzerland are less prone to attacks by criminals, but their future remains uncertain given the less active use of cash by the population.
This content was published on
A series of rockfalls occurred above the village of Brienz between 9 and 12 July. According to the municipality of Albula, the overall situation remains tense. Several people disregarded the ban on entering the area around the village.
This content was published on
Arosa Bergbahnen achieved the highest figure in its 95-year history in the 2024/25 financial year with net revenue of CHF 37 million. Arosa Lenzerheide was able to capitalise on strengths such as snow reliability and the size of the ski area in a long winter season, the company announced on Thursday.
This content was published on
Unknown perpetrators stole ceramic dental implants during a break-in at a company in Oensingen, northern Switzerland, on Tuesday night.
Euro 2025: Bern prepares for massive parade ahead of Switzerland-Spain game
This content was published on
The last Euro 2025 match to be played in Bern, the quarterfinal between Spain and Switzerland at 9pm on Friday, promises to be a great celebration of football.
Clariant faces further ethylene price-fixing claim
This content was published on
Swiss chemicals group Clariant is facing a further claim for damages in connection with ethylene price-fixing agreements.
This content was published on
The Grande Dixence dam in Lower Valais is closed to visitors due to a rockfall last weekend. The nearby hotel also had to temporarily suspend operations for safety reasons.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.